opzelura
incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - muut dermatologiset valmisteet - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
strepsils hunaja & sitruuna 1.2 mg / 0.6 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi
strepsils menthol 1.2 mg / 0.6 mg / 8.0 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol, menthol - imeskelytabletti - 1.2 mg / 0.6 mg / 8.0 mg - diklooribentsyylialkoholi
strepsils appelsiini 1.2 mg / 0.6 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi
strepsils mint 1.2 mg / 0.6 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi
strepsils mansikka 1.2 mg / 0.6 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi
strepsils inkivääri 1.2 mg / 0.6 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi
strepsils sitrus 1.2 mg / 0.6 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - dichlorbenzylalcohol, amylmetacresol - imeskelytabletti - 1.2 mg / 0.6 mg - diklooribentsyylialkoholi